Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment

被引:40
作者
Dung, Tran Huu
Lee, Seung-Rok
Han, Suhk-Dong
Kim, Seon-Jeong
Ju, Yeon-Mi
Kim, Myong-Soo
Yoo, Hoon [1 ]
机构
[1] Chosun Univ, Coll Dent, Dept Pharmacol & Dent Therapeut, Kwangju 501759, South Korea
[2] Chosun Univ, Coll Sci, Dept Chem, Kwangju 501759, South Korea
关键词
chitosan; nanoparticle; antisense oligonucleoticle; release;
D O I
10.1166/jnn.2007.041
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Antisense oligonucleotide loaded chitosan nanoparticles were prepared and the release of oligonucleotide from chitosan-TPP/oligonucleotide nanoparticles was investigated. Morphological property, zeta potential and particle size of the prepared chitosan/oligonucleotide nanoparticles were investigated using Field Emission-Scanning Electron Microscope (FE-SEM) and particle size analyzer. The interaction between chitosan and oligonucleoticle was confirmed by using capillary zone electrophoresis (CZE), and the released oligonucleoticles were determined by spectrophotometric method. Oligonucleoticles formed the complexes with chitosan with a unique morphological property. The release of oligonucleotides from nanoparticles was dependent on loading methods and pH conditions. Chitosan/oligomer-TPP nanoparticles, which was prepared by adding TPP after the formation of chitosan/oligonucleoticle complex, showed the lowest release percent of oligonucleotides with 41.3% at pH 7.0 among the loading methods. The percent release of oligonucleoticle from oligonucleoticle loaded chitosan nanoparticle at pH 10 was higher than the one in acidic condition (pH 5.0). The released oligonucleoticles from chitosan/oligonucleoticle nanoparticles were stable enough for 12 h under the 20% saliva solution. Our results suggest that the sustained release of oligonucleoticle from chitosan nanoparticles may be suitable for the local therapeutic application in periodontal diseases.
引用
收藏
页码:3695 / 3699
页数:5
相关论文
共 25 条
[1]   Perspectives in antisense therapeutics [J].
Agrawal, S ;
Iyer, RP .
PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) :151-160
[2]   Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis [J].
Bivas-Benita, M ;
van Meijgaarden, KE ;
Franken, KLMC ;
Junginger, HE ;
Borchard, G ;
Ottenhoff, THM ;
Geluk, A .
VACCINE, 2004, 22 (13-14) :1609-1615
[3]   Preparation and characterization of chitosan-based nanoparticles [J].
Bodnar, M ;
Hartmann, JF ;
Borbely, J .
BIOMACROMOLECULES, 2005, 6 (05) :2521-2527
[4]   In vitro antimicrobial activity of a chitooligosaccharide mixture against Actinobacillus actinomycetemcomitans and Streptococcus mutans [J].
Choi, BK ;
Kim, KY ;
Yoo, YJ ;
Oh, SJ ;
Choi, JH ;
Kim, CY .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (06) :553-557
[5]   Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds [J].
DeFail, Alicia J. ;
Edington, Howard D. ;
Matthews, Stacey ;
Lee, Wen-Chi C. ;
Marra, Kacey G. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 79A (04) :954-962
[6]   Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery [J].
Gan, Q ;
Wang, T ;
Cochrane, C ;
McCarron, P .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 44 (2-3) :65-73
[7]   MULTICENTER EVALUATION OF TETRACYCLINE FIBER THERAPY .3. MICROBIOLOGICAL RESPONSE [J].
GOODSON, JM ;
TANNER, A ;
MCARDLE, S ;
DIX, K ;
WATANABE, SM .
JOURNAL OF PERIODONTAL RESEARCH, 1991, 26 (05) :440-451
[8]   Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis [J].
Ikinci, G ;
Senel, S ;
Akincibay, H ;
Kas, S ;
Ercis, S ;
Wilson, CG ;
Hincal, AA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 235 (1-2) :121-127
[9]   Chitosan nanoparticles as delivery systems for doxorubicin [J].
Janes, KA ;
Fresneau, MP ;
Marazuela, A ;
Fabra, A ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :255-267
[10]   Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides [J].
Juliano, RL ;
Alahari, S ;
Yoo, H ;
Kole, R ;
Cho, M .
PHARMACEUTICAL RESEARCH, 1999, 16 (04) :494-502